Abstract
The spectrum of mutations of the RET proto-oncogene was analyzed in Russian patients with inherited or sporadic medullary thyroid carcinoma (MTC). Four RET exons (11, 13, 15, and 16) were subjected to molecular analysis, and mutations were revealed and identified in 47.4% (9/19) patients with sporadic MTC. In total, six different mutations (including three new ones) were observed. The most common mutation affected codon 918 to cause substitution of methionine with threonine and accounted for 31.6% alleles. Analysis of exons 11 and 16 revealed four types of mutations in patients with inherited multiple endocrine neoplasia type 2 (MEN 2). Mutations were found in each patient. Thyroidectomy was performed in four asymptomatic carriers of RET mutations from three MEN 2A families (in two families, affected relatives had bilateral pheochromocytoma). In two patients, analysis of the surgery material revealed MTC microfoci in both lobes of the thyroid gland. The results provide the ground for constructing a bank of genetic information on Russian MTC patients with the clinically verified diagnosis.
Similar content being viewed by others
References
Schimke, R.N., Genetic Aspects of Multiple Endocrine Neoplasia, Annu. Rev. Med., 1984, vol. 35, pp. 25-31.
Gorlin, R.J., Sedano, H.O., Vickers, R.A., et al., Multiple Mucosal Neuromas, Pheochromocytoma and Medullary Carcinoma of the Thyroid—A Syndrome, Cancer, 1968, vol. 22, no. 2, pp. 293-299.
Farndon, J.R., Leight, G.S., Dilley, W.G., et al., Familial Medullary Thyroid Carcinoma without Associated Endocrinopathies: A Distinct Clinical Entity, Br. J. Surg., 1986, vol. 73, pp. 278-281.
Hofstra, R.M.W., Landsvater, R.M., Ceccherini, J., et al., A Mutation in the RET Proto-oncogene Associated with Multiple Endocrine Neoplasia Type 2B and Sporadic Medullary Thyroid Carcinoma, Nature, 1994, vol. 367, no. 6461, pp. 375-376.
Mulligan, L.M., Kwok, J.B., Healey, C.S., et al., Germ-Line Mutations of the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2A, Nature, 1993, vol. 363, no. 6428, pp. 458-460.
Amosenko, F.A., Kalinin, V.N., Kozlova, V.M., et al., Mutations of the RET Proto-oncogene in Patients with Medullary Thyroid Carcinoma and the Possibilities of Presymptomatic Diagnostics and Preventive Treatment of This Disorder, Vestn. Ross. Onkol. Nauchn. Tsentra im. N.N. Blokhina, 2000, no. 1, pp. 20-26.
Carlson, K.M., Dou, S., Chi, D., et al., Single Missense Mutation in the Tyrosine Kinase Catalytic Domain of the RET Proto-oncogene Is Associated with Multiple Endocrine Neoplasia Type 2B, Proc. Natl. Acad. Sci. USA, 1994, vol. 91, no. 4, pp. 1579-1583.
Rossel, M., Schuffenecker, I., Schlumberger, M., et al., Detection of a Germline Mutation at Codon 918 of the RET Proto-oncogene in French MEN 2B Families, Hum. Genet., 1995, vol. 95, no. 4, pp. 403-406.
Lips, C.J.M., Landsvater, R.M., Hoppener, J.W.M., et al., Clinical Screening as Compared with DNA Analysis in Families with Multiple Endocrine Neoplasia Type 2A, N. Engl. J. Med., 1994, vol. 331, pp. 828-835.
Schuffenecker, I., Billaud, M., Calender, A., et al., RET Proto-oncogene Mutations in French MEN 2A and FMTC Families, Hum. Mol. Genet., 1994, vol. 3, no. 11, pp. 1939-1943.
GenBank USA, accession no. AF082330-AF082337.
Amosenko, F.A., Trubnikova, I.S., Zakharyev, V.M., et al., UB9 Polymorphism in the CFTR Gene of Cystic Fibrosis Patients, Carriers, and Healthy Donors from the Moscow Region: SSCP and Restriction Enzyme Analyses, Genetics, 1997, vol. 33, no. 2, pp. 198–202.
Eng, C., Smith, D.P., Mulligan, L.M., et al., Point Mutation within the Tyrosine Kinase Domain of the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2B and Related Sporadic Tumors, Hum. Mol. Genet., 1994, vol. 3, pp. 237-241.
Kalinin, V.N., Olek, K., Shmidt, V., et al., Allele-Specific Sequencing, Dokl. Akad. Nauk, 1995, vol. 343, no. 5, pp. 692-694.
Kalinin, V.N., Amosenko, F.A., Shabanov, M.A., et al., Three Novel Mutations in the RET Proto-oncogene as Somatic Mutations Associated with Medullary Thyroid Carcinoma, J. Mol. Med., 2001, vol. 79, no. 10, pp. 609-612.
Asai, N., Iwashita, T., Matsuyama, M., et al., Mechanism of Activation of the RET Proto-oncogene by Multiple Endocrine Neoplasia 2A Mutations, Mol. Cell. Biol., 1995, vol. 15, pp. 1613-1619.
Borrello, M.G., Smith, D.P., Pasini, B., et al., RET Activation by Germline MEN 2A and MEN 2B Mutations, Oncogene, 1995, vol. 11, pp. 2419-2427.
Santoro, M., Carlomagno, F., Romano, A., et al., Activation of RET as Dominant Transforming Gene by Germline Mutations of MEN 2A and MEN 2B, Science, 1995, vol. 267, no. 5196, pp. 381-383.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amosenko, F.A., Brzhezovskiy, V.Z., Lyubchenko, L.N. et al. Analysis of Mutations of the RET Proto-oncogene in Patients with Medullary Thyroid Carcinoma. Russian Journal of Genetics 39, 706–711 (2003). https://doi.org/10.1023/A:1024474314212
Issue Date:
DOI: https://doi.org/10.1023/A:1024474314212